Blood Thinner and Heart Attack Prevention Study
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether taking dabigatran (a blood thinner) combined with ticagrelor (a blood clot preventer) is safe and effective for patients with irregular heart rhythm (atrial fibrillation) who recently had a heart attack and received a stent. The goal is to prevent future blood clots while minimizing bleeding risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a recent heart attack (within the last 120 hours) and received a stent to open a blocked artery
- You have atrial fibrillation (irregular heartbeat) and are either already taking or willing to start dabigatran
- You have no serious kidney, liver, or bleeding problems
- You have not had major surgery, stroke, or significant bleeding in the past month
- You are willing to take two blood-thinning medications and avoid certain drug interactions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different blood-thinner (“antithrombotic”) strategies in people with atrial fibrillation or flutter who recently had a stent placed (PCI). It aims to find a plan that lowers clot risk while keeping bleeding risk as low as possible.
This study compares ticagrelor taken at a lower dose versus regular aspirin to help prevent future heart attacks in people who recently had a stent placed after acute coronary syndrome. You may qualify if you’re considered “high risk” for new blockages or clots and can take dual anti-platelet therapy for 12 months.
This trial studies whether changing the timing and type of blood-thinner tablets after a heart stent is as safe and effective as continuing the same plan. It may help some people by simplifying treatment while preventing dangerous clotting after a coronary procedure.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests whether patients with both irregular heartbeat (atrial fibrillation) and a recent heart attack can safely take a shorter course of blood-thinning medications after a stent procedure. The goal is to reduce bleeding risk while still protecting against future clots.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.